• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL PUERTO RICO, INC. SJM REGENT HEART VALVE; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL PUERTO RICO, INC. SJM REGENT HEART VALVE; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 23AGN-751
Device Problems Material Separation (1562); Patient-Device Incompatibility (2682)
Patient Problems Hemolysis (1886); Pseudoaneurysm (2605)
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
The article, "bentall surgery for acute type a aortic dissection and re-repair surgery for hemolysis due to aortic root anastomotic pseudoaneurysm and artificial vessel flexion after ascending arch aortic procedure replacement" was reviewed.The research article presents a case study on a (b)(6) male who underwent emergency bentall surgery four years ago.The patient was implanted with a 23mm sjm regent artificial heart valve, 26mm triplex and the aortic arch was replaced with a 22mm triplex.The artificial blood vessel flexion was resected twice due to hemolysis.The patients hemolysis continued to reoccur and a contrast-enhanced ct was performed.A pseudoaneurysm caused by suture site detachment of the artificial heart valve and severe bent of elephant trunk at proximal to descending aorta were confirmed.The patient underwent re-operation and there were no adhesions to the pseudoaneurysm.Since the tissue on the heart side was healthy, the artificial valve was re-fixed.6 stitches were sewn to supra-annular on the base of the anterior leaflet of the mitral valve, the annulus, the artificial blood vessel, and the mechanical heart valve annulus.The non-coronary cusp(ncc) side was also fixed to reinforce 3 stitches.After that, only the stent part of open stent graft (frozenix 23 mm, stent length 150 mm) was placed in the bent part, and the procedure was completed.The operation time was over 12 hours, but postoperative hemolysis improved.Contrast-enhanced ct confirmed that there was no recurrence of pseudoaneurysm.The patient was discharged 30 days after the operation.3 month post-procedure, no hemolysis was confirmed and the patient got back to the society uneventfully.
 
Manufacturer Narrative
Corrected information for: h6.Additional information for: g3, g6, h2, h6, and h10.As reported in a research article, a patient was implanted with a 23mm sjm regent heart valve in the aortic position, a 26mm triplex, and had the aortic arch replaced with a 22mm triplex; an event of pseudoaneurysm, suture site detachment, reoperation, and hemolysis were reported.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM REGENT HEART VALVE
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ST. JUDE MEDICAL PUERTO RICO, INC.
p.o. box 998
lot 20 b st.
caguas, puerto rico 00725
MDR Report Key11542328
MDR Text Key241494777
Report Number2648612-2021-00022
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 04/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number23AGN-751
Device Catalogue Number23AGN-751
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/24/2021
Initial Date FDA Received03/22/2021
Supplement Dates Manufacturer Received04/12/2021
Supplement Dates FDA Received04/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age51 YR
-
-